| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |